총 2,523건 중 1,000건 출력
, 1/100 페이지
-
1
-
Practical reliability. Vol. I. Parameter variations analysis - NASW-1448, UDC. 658.562/519.3/519.283, July (1968), 84 pp
-
;
;
(Microelectronics and reliability,
v.8,
1969,
pp.287-288)
-
2
-
[Bioavailability of 3.519 CERM: influence of dosage form additives (author's transl)].
-
A?ache, J M;
Pognat, J F;
Boudal, P;
;
(Journal de pharmacie de Belgique,
v.35,
1980,
pp.85-97)
-
3
-
About the Luminous Blue Variable He3-519
-
Herve, A.;
Bouret, J.-C.;
;
(Active OB Stars; structure, evolution, mass loss, and critical limits,
v.2011,
2011,
pp.87-88)
-
4
-
About the Luminous Blue Variable He3-519
-
Herve, A.;
Bouret, J.-C.;
;
(Symposium : International Astronomical Union,
v.272,
2011,
pp.87-88)
-
5
-
About the Luminous Blue Variable He3-519
-
Hervé
, Anthony;
Bouret, Jean-Claude;
;
(Proceedings of the International Astronomical Union,
v.6,
2010,
pp.87-88)
-
6
-
519.3: A HYBRID NONCONFORMAL FETI/CONFORMAL FETI-DP METHOD FOR ARBITRARY NONOVERLAPPING DOMAIN DECOMPOSITION MODELING
-
Xue, M.-F.;
Jin, J.-M.;
;
(Digest : IEEE Antennas and Propagation Society International Symposium,
v.2013,
2013,
pp.1628-1629)
-
7
-
MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3
-
Chu, Chengling;
Liu, Xin;
Bai, Xue;
Zhao, Tong;
Wang, Mengxue;
Xu, Ranchen;
Li, Mingqi;
Hu, Yingying;
Li, Weihua;
Yang, Lida;
Qin, Youyou;
Yang, Meng;
Yan, Chaoqi;
Zhang, Yong;
Department of Oncology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China;
;
Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin 150081, China;
;
Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin 150081, China;
;
Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin 150081, China;
;
Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Educatio;
(International journal of biological sciences,
v.14,
2018,
pp.228-236)
-
8
-
Sauve v. Canada [2002] 3 S.C.R. 519
-
;
;
(The Canadian bar review,
v.83,
2004,
pp.261)
-
9
-
The mIRNA519a-3p and NKG2D in endometriosis.
-
Pramayadi Cepi Teguh;
Natadisastra Muharam;
Sumapradja Kanadi;
Kekalih Aria;
;
(Indonesian Journal of Obstetrics and Gynecology,
v.,
2022,
pp.223-228)
-
10
-
MiR-519d and miR-328-3p Combinatorially Suppress Breast Cancer Progression
-
Ma, Haiming;
Liu, Tao;
Xu, Yanhua;
Wang, Xinying;
Wang, Jin;
Liu, Xiaokang;
Department of Oncology, Guangrao County People’s Hospital , Dongying City , Shandong Province 257300 , People’s Republic of China;
Department of General Surgery, Guangrao County People’s Hospital , Dongying City , Shandong Province 257300 , People’s Republic of China;
Department of Anesthesiology, Guangrao County People’s Hospital , Dongying City , Shandong Province 257300 , People’s Republic of China;
Department of Pathology, Guangrao County People’s Hospital , Dongying City , Shandong Province 257300 , People’s Republic of China;
Department of Oncology, Guangrao County People’s Hospital , Dongying City , Shandong Province 257300 , People’s Republic of China;
Department of Oncology, Guangrao County People’s Hospital ,;
(OncoTargets and therapy,
v.13,
2020,
pp.12987-12997)